IHEvsIWM
iShares U.S. Pharmaceuticals ETF against iShares Russell 2000 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IHE | IWM | |
|---|---|---|
| Expense ratio | 0.40% | 0.19% |
| Assets | $1.5B | $74.2B |
| Net flow, 1 month | −$130M | −$1.6B |
| Net flow, 1 year | +$666M | −$4.4B |
| Return, YTD | +21.8% | +13.8% |
| Return, 1 year | +37.6% | +11.9% |
| Avg daily volume | 274K | 24.9M |
| Holdings | 38 | 1941 |
| Listed | May 1, 2006 | May 22, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS